𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Pharmacokinetics of aditoprim in normal and febrile sheep

✍ Scribed by Dr. M. Perwaiz Iqbal; Sarfaraz K. Niazi; M. Khalid Ashfaq; N. Mahboobali


Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
309 KB
Volume
16
Category
Article
ISSN
0142-2782

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Pharmacokinetics of aditoprim and trimet
✍ M. Perwaiz Iqbal; M. Khalid Ashfaq; Sarfaraz K. Niazi; M. Mahboobali; Khalid N. πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 250 KB

Pharmacokinetic parameters of two antifolates, trimethoprim and aditoprim, were studied in buffalo calves. The elimination half-life of aditoprim (6-14 h) was nearly twice as long as that of trimethoprim (3.08h) and compares well with values observed in heifers. This longer half-life of aditoprim is

Pharmacokinetics of aditoprim in goats u
✍ M. Perwaiz Iqbal; N. Mahboobali; Sarfaraz K. Niazi; M. Anwar Mahmood πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 373 KB

## Abstract A simple, highly sensitive radioassay was developed for the activity of a newly discovered inhibitor of dihydrofolate reductase (DHFR), aditoprim. The procedure is based on the inhibition of binding of [^3^H]‐methotrexate ([^3^H]MTX) with bacterial dihydrofolate reductase by the antifol

Pharmacokinetics and tissue disposition
✍ Quintin A. McKellar; Ian F. Gibson; Robert Z. McCormack πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 172 KB πŸ‘ 2 views

The plasma pharmacokinetics of danofloxacin administered at 1.25 mg kg -1 body weight by the intravenous and intramuscular routes were determined in sheep. Tissue distribution was also determined following administration by the intramuscular route at 1.25 mg kg -1 body weight. Danofloxacin had a lar

A comparison of nonlinear pharmacokineti
✍ P. Veng-Pedersen; J.A. Widness; L.M. Pereira; R.L. Schmidt; L.S. Lowe πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 146 KB πŸ‘ 2 views

The primary mechanism of erythropoietin's (EPO) in vivo elimination and the tissue, or tissues, responsible are unknown. Previous studies indicating that EPO pharmacokinetic (PK) behaviour is nonlinear suggest that EPO elimination takes place by a saturable mechanism. A versatile PK system analysis,